4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-21-009113
Chief Financial Officer sold 390 shares at $7.66 ($2,987)
- Chief Financial Officer acquired 892 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Broadfoot Jill Marie Chief Financial Officer | 2021-02-06 | Option exercise | +892 | 10,223 | D | ||
| Broadfoot Jill Marie Chief Financial Officer | 2021-02-09 | Sale | −390 | $7.66 | $2,987 | 9,833 | D |
| Derivatives | |||||||
| Broadfoot Jill Marie Chief Financial Officer | 2021-02-06 | Option exercise · Restricted Stock Unit | −892 | 0 | D | ||
| Open-market sales · 390 sh · avg $7.66 · $2,987 | |||||||
Loading xslF345X03/doc4.xml…